Clinical Trials in Texas

Browse 239 Texas Medical Studies Across 1224 Cities
114 Phase 3 Trial · 8817 Texas Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Texas

Reviewed by Michael Gill, B. Sc.

Image of Elite Clinical Studies, LLC in Phoenix, United States.

Phase-Based Progress Estimates

Difamilast Ointmentfor Dermatitis

This is a Phase 3 Double Blind multi-center study conducted at 40 investigational sites in United States to assess the efficacy and safety of Difamilast Ointment 1% in subjects ≥2 years of age with mild to moderate atopic dermatitis.

Elite Clinical Studies, LLC (+12 Sites)Uma Srinivas Atmuri, MPharm MSAcrotech Biopharma Inc.

Image of Limb Preservation Platform, Inc. in Fresno, United States.

Phase-Based Progress Estimates

Plasma Filmfor Diabetic Foot Ulcers (DFUs)

The goal of this clinical trial is to determine the safety of DERMASEAL for the treatment of non-healing, neuropathic diabetic foot ulcers. The main outcome measure is safety. A total of twenty-four (24) participants will be randomized to receive up to four (4) consecutive weeks of treatment with either standard of care (SOC), plasma film + SOC, or plasma film containing silver microparticles (DERMASEAL) + SOC, with a final follow-up visit 12 weeks after the last treatment.

Limb Preservation Platform, Inc. (+2 Sites)Vitruvian Medical Devices, Inc.

Image of Preferred Primary Care Physicians in Uniontown, United States.

Phase-Based Progress Estimates

PF-07081532 20 Mg T2DMfor Diabetes Mellitus

The purpose of this study is to find out if PF-07081532 ("the active study drug"), is safe and helps treat people with obesity without diabetes to lose weight, and people with diabetes to keep their blood sugar in good control. Individuals diagnosed with diabetes that are on metformin or individuals with obesity without diabetes will be included in the study. Those participating in the diabetes part of the study, will receive either active study drug, placebo, or an approved treatment called Rybelsus. Those in the obesity part of the study, will receive either active study drug or placebo. The study will last for about 36 weeks except for the first 25% of the participants that enter in which case the study will last for approximately 48 weeks. during this time there will be visits every 4 weeks with phone calls in between.

Preferred Primary Care Physicians (+15 Sites)Pfizer CT.gov Call CenterPfizer

Image of North Alabama Research Center, LLC in Athens, United States.

Phase-Based Progress Estimates

MRNA-1010for Hay fever

This trial will test if a new vaccine can prevent seasonal influenza in adults aged 50 and over.

North Alabama Research Center, LLC (+99 Sites)ModernaTX, Inc.

Image of Neighborhood Healthcare Institute of Health in Escondido, United States.

Phase-Based Progress Estimates

Tirzepatidefor Overweight

This trial will look at whether tirzepatide can reduce obesity-related health problems and death in adults.

Neighborhood Healthcare Institute of Health (+78 Sites)Call 1-877-CTLILLY (1-877-285-4559 or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of Novo Nordisk Investigational Site in Birmingham, United States.

Phase-Based Progress Estimates

Semaglutidefor Diabetes Mellitus, Type 2

This trial is testing whether semaglutide can help control blood sugar and weight in people with type 2 diabetes who are also overweight, when taken with metformin. It will compare different doses of semaglutide, given by injection, to placebo (a dummy medicine). The trial will last for 52 weeks, with participants having 13 clinic visits and 4 phone calls.

Novo Nordisk Investigational Site (+54 Sites)Clinical Transparency (dept. 2834)Novo Nordisk A/S

Image of Novo Nordisk Investigational Site in Pembroke Pines, United States.

Phase-Based Progress Estimates

Semaglutide Jfor Diabetes Mellitus, Type 2

This trial is testing a new way to make the diabetes drug semaglutide, to see if it controls blood sugar better than the current version.

Novo Nordisk Investigational Site (+45 Sites)Clinical Transparency (dept. 2834)Novo Nordisk A/S

Image of Western Sky Medical Research in El Paso, United States.

Phase-Based Progress Estimates

Remibrutinib High Dosefor Peanut Allergies

A study to evaluate the safety, efficacy and tolerability of remibrutinib at three doses versus placebo in adult participants who have a confirmed allergy to peanuts. The efficacy will be measured by the ability of participants to tolerate increasing doses of peanut protein during an oral food challenge after 1 month of study treatment.

Western Sky Medical ResearchNovartis Pharmaceuticals

Image of Novo Nordisk Investigational Site in Roswell, United States.

Phase-Based Progress Estimates

IcoSemafor Diabetes Mellitus, Type 2

This trial will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin icodec taken once a week in people with type 2 diabetes, in terms of blood sugar control.

Novo Nordisk Investigational Site (+62 Sites)Clinical Transparency (dept. 2834)Novo Nordisk A/S

Image of Piedmont Hospital in Atlanta, United States.

Phase-Based Progress Estimates

SAPIEN X4 THVfor Aortic Valve Stenosis

This trial is testing a new heart valve to see if it is safe and effective for people with a certain type of heart problem.

Piedmont Hospital (+20 Sites)Rahul P. Sharma, MBBSEdwards Lifesciences

Image of Accel Research Sites - Cahaba Medical Care in Birmingham, United States.

Phase-Based Progress Estimates

Elinzanetant (BAY3427080)for Hot Flashes

This trial is looking for a better way to treat women who have hot flashes after going through menopause. Elinzanetant is a new treatment that blocks a protein called neurokinin from sending signals to other parts of the body. The study will compare elinzanetant to a placebo in women who have been through the menopause and have hot flashes.

Accel Research Sites - Cahaba Medical Care (+45 Sites)Bayer

Image of The University of Arizona Cancer Center (UACC) - North Campus in Tucson, United States.

Phase-Based Progress Estimates

SM08502for Carcinoma, Non-Small-Cell Lung

Waitlist Available

FDA Approved Drug

This trial is testing a new drug, SM08502, for safety and effectiveness in treating advanced solid tumors, either alone or in combination with other cancer treatments.

Waitlist Available

FDA Approved Drug

The University of Arizona Cancer Center (UACC) - North Campus (+23 Sites)Darrin Beaupre, MD, PhD, CMOBiosplice Therapeutics, Inc.

Image of Prometheus Biosciences Selected Site in Chesterfield, United States.

Phase-Based Progress Estimates

Companion Diagnostic (CDx)for Ileocolitis

Waitlist Available

This trial is testing a new drug for Crohn's Disease to see if it is safe and effective. Participants will take the drug for 12 weeks and then can choose to continue taking it for an additional 38 weeks.

Waitlist Available

Prometheus Biosciences Selected Site (+15 Sites)Prometheus BiosciencesPrometheus Biosciences, Inc.

Image of Ironwood Cancer & Research Centers in Chandler, United States.

Phase-Based Progress Estimates

LY3484356for Breast Cancer

FDA Approved Drug

This trial is testing a new drug to see if it's more effective than standard hormone therapy for treating breast cancer.

FDA Approved Drug

Ironwood Cancer & Research Centers (+40 Sites)Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of West Tennessee Research Institute in Jackson, United States.

Phase-Based Progress Estimates

CC-99677for Spondylitis, Ankylosing

This trial will study the effects of CC-99677 on patients with Ankylosing Spondylitis over 12 weeks, measuring symptoms, disease activity, quality of life, safety, and tolerability.

West Tennessee Research Institute (+20 Sites)Robert Wong, MDCelgene

Image of Novo Nordisk Investigational Site in Madison, United States.

Phase-Based Progress Estimates

Semaglutidefor Nonalcoholic Steatohepatitis

FDA Approved Drug

This trial is studying a medication called semaglutide in patients with NASH. Semaglutide is a well-known medication used to treat type 2 diabetes, and participants will either receive semaglutide or a dummy medication, with no way of knowing which they're getting. The study will last for 5 years, during which participants will have to inject themselves weekly and will have 21 clinic visits and 9 phone calls with clinical staff. Some of the clinic visits may last more than one day.

FDA Approved Drug

Novo Nordisk Investigational Site (+69 Sites)Clinical Transparency (dept. 1452)Novo Nordisk A/S

Image of Arizona Pulmonary Specialists, Ltd. in Phoenix, United States.

Phase-Based Progress Estimates

Inhaled Treprostinilfor Usual Interstitial Pneumonia

FDA Approved Drug

This trial will study the safety and effectiveness of inhaled treprostinil in people with a lung disease called idiopathic pulmonary fibrosis.

FDA Approved Drug

Arizona Pulmonary Specialists, Ltd. (+71 Sites)United Therapeutics

Image of Cook Childrens Medical Center in Fort Worth, United States.

Phase-Based Progress Estimates

Crizanlizumabfor Anemia, Sickle Cell

FDA Approved Drug

This trial will allow continued access to the drug crizanlizumab for patients with sickle cell disease who are benefiting from the treatment.

FDA Approved Drug

Cook Childrens Medical Center (+5 Sites)Novartis PharmaceuticalsNovartis Pharmaceuticals

Image of Central Research Associates, Inc. in Birmingham, United States.

Phase-Based Progress Estimates

RSVpreFfor Respiratory Tract Infections

Waitlist Available

This trial will test if a RSV vaccine is safe and effective in pregnant women and their infants.

Waitlist Available

Central Research Associates, Inc. (+99 Sites)Pfizer CT.gov Call CenterPfizer

Image of Highlands Oncology Group Main in Fayetteville, United States.

Phase-Based Progress Estimates

Alpelisibfor Advanced HER2+Breast Cancer

FDA Approved Drug

This trial is testing whether a new drug is effective and safe for people with a certain type of breast cancer.

FDA Approved Drug

Highlands Oncology Group Main (+22 Sites)Novartis PharmaceuticalsNovartis Pharmaceuticals

Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

Phase-Based Progress Estimates

Capecitabinefor Cancer of Colon

FDA Approved Drug

This trial tests how well ctDNA testing in the blood predicts treatment for patients with stage IIA colon cancer after surgery. ctDNA are circulating tumor cells that are shed by tumors into the blood. Finding ctDNA in the blood means that there is very likely some small amounts of cancer that remain after surgery. However, this cancer, if detected, cannot be found on other tests usually used to find cancer, as it is too small. Testing for ctDNA levels may help identify patients with colon cancer after surgery who do benefit, and those who do not benefit, from receiving chemotherapy.

FDA Approved Drug

NRG Oncology - Pittsburgh Center (+99 Sites)Van K Morris

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Phase-Based Progress Estimates

ASTX295for Tumors, Solid

This trial is testing a new drug, ASTX295, to see if it is safe and effective in treating people with certain types of cancer. The trial will have two parts, with the first part testing different doses of the drug to see what is safe and what works best.

Cedars-Sinai Medical Center (+18 Sites)Kim-Hein Dao, DO, PhDAstex Pharmaceuticals, Inc.

Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Phase-Based Progress Estimates

Laboratory Biomarker Analysisfor Cardiotoxicity

FDA Approved Drug

This trial studies the effects of carvedilol on preventing heart problems in patients with HER2-positive breast cancer.

FDA Approved Drug

City of Hope Comprehensive Cancer Center (+99 Sites)Justin Floyd

Image of Mayo Clinic Cancer Center in Phoenix, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Cancer of Pancreas

FDA Approved Drug

This trial will study whether it is safe to give pembrolizumab in combination with neoadjuvant (before surgery) chemotherapy and radiation therapy for patients with resectable or borderline resectable pancreatic cancer.

FDA Approved Drug

Mayo Clinic Cancer Center (+4 Sites)Osama Rahma, MD

Image of Medical Facility in Cullman, United States.

Phase-Based Progress Estimates

Sulopenem Etzadroxil/probenecidfor Urinary Tract Infections

IT001-310 is a clinical study which compares the effectiveness of oral sulopenem versus oral amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection.

Medical Facility (+49 Sites)Sailaja Puttagunta, MDIterum Therapeutics, International Limited

25 Texas Clinical Trials Near Me

Top Cities for Texas Clinical Trials

Image of Houston in Texas.

Houston

185Active Trials

Baylor College of MedicineTop Active Site

Image of Los Angeles in California.

Los Angeles

149Active Trials

Kaiser Permanente Los Angeles Medical CenterTop Active Site